Preclinical characterization and anti-SARS-CoV-2 efficacy of ATV014: an oral cyclohexanecarboxylate prodrug of 1'-CN-4-aza-7,9-dideazaadenosine C-nucleoside.
Qifan ZhouSidi YangLiu CaoYang YangTiefeng XuQishu ChenHongzhou LuYingjun LiDe-Ying GuoXumu ZhangPublished in: Signal transduction and targeted therapy (2023)